ABBOTT LABORATORIES (ABL.DE) Fundamental Analysis & Valuation

FRA:ABL • US0028241000

Current stock price

89.24 EUR
-0.48 (-0.53%)
Last:

This ABL.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. ABL.DE Profitability Analysis

1.1 Basic Checks

  • In the past year ABL was profitable.
  • In the past year ABL had a positive cash flow from operations.
  • ABL had positive earnings in each of the past 5 years.
  • Each year in the past 5 years ABL had a positive operating cash flow.
ABL.DE Yearly Net Income VS EBIT VS OCF VS FCFABL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • With an excellent Return On Assets value of 7.52%, ABL belongs to the best of the industry, outperforming 85.25% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 12.51%, ABL belongs to the top of the industry, outperforming 80.33% of the companies in the same industry.
  • ABL's Return On Invested Capital of 9.17% is fine compared to the rest of the industry. ABL outperforms 75.41% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ABL is in line with the industry average of 10.18%.
  • The 3 year average ROIC (8.63%) for ABL is below the current ROIC(9.17%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.52%
ROE 12.51%
ROIC 9.17%
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
ABL.DE Yearly ROA, ROE, ROICABL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • The Profit Margin of ABL (14.72%) is better than 88.52% of its industry peers.
  • In the last couple of years the Profit Margin of ABL has grown nicely.
  • With a decent Operating Margin value of 18.85%, ABL is doing good in the industry, outperforming 78.69% of the companies in the same industry.
  • ABL's Operating Margin has improved in the last couple of years.
  • ABL has a Gross Margin (56.68%) which is in line with its industry peers.
  • ABL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.85%
PM (TTM) 14.72%
GM 56.68%
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
ABL.DE Yearly Profit, Operating, Gross MarginsABL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. ABL.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ABL is destroying value.
  • Compared to 1 year ago, ABL has more shares outstanding
  • Compared to 5 years ago, ABL has less shares outstanding
  • ABL has a better debt/assets ratio than last year.
ABL.DE Yearly Shares OutstandingABL.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
ABL.DE Yearly Total Debt VS Total AssetsABL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

2.2 Solvency

  • ABL has an Altman-Z score of 4.87. This indicates that ABL is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of ABL (4.87) is better than 81.97% of its industry peers.
  • ABL has a debt to FCF ratio of 1.75. This is a very positive value and a sign of high solvency as it would only need 1.75 years to pay back of all of its debts.
  • The Debt to FCF ratio of ABL (1.75) is better than 81.97% of its industry peers.
  • A Debt/Equity ratio of 0.19 indicates that ABL is not too dependend on debt financing.
  • The Debt to Equity ratio of ABL (0.19) is better than 72.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.75
Altman-Z 4.87
ROIC/WACC0.88
WACC10.38%
ABL.DE Yearly LT Debt VS Equity VS FCFABL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • ABL has a Current Ratio of 1.58. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
  • ABL has a Current ratio (1.58) which is comparable to the rest of the industry.
  • A Quick Ratio of 1.18 indicates that ABL should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.18, ABL is in line with its industry, outperforming 54.10% of the companies in the same industry.
  • The current and quick ratio evaluation for ABL is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.18
ABL.DE Yearly Current Assets VS Current LiabilitesABL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ABL.DE Growth Analysis

3.1 Past

  • ABL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.28%, which is quite good.
  • Measured over the past 5 years, ABL shows a small growth in Earnings Per Share. The EPS has been growing by 7.13% on average per year.
  • Looking at the last year, ABL shows a small growth in Revenue. The Revenue has grown by 5.67% in the last year.
  • The Revenue has been growing slightly by 5.08% on average over the past years.
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.38% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 7.06% on average over the next years.
EPS Next Y11.53%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
EPS Next 5Y10.38%
Revenue Next Year6.97%
Revenue Next 2Y7.18%
Revenue Next 3Y7.13%
Revenue Next 5Y7.06%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ABL.DE Yearly Revenue VS EstimatesABL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
ABL.DE Yearly EPS VS EstimatesABL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

4

4. ABL.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 19.92 indicates a rather expensive valuation of ABL.
  • 75.41% of the companies in the same industry are more expensive than ABL, based on the Price/Earnings ratio.
  • ABL's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.75.
  • A Price/Forward Earnings ratio of 17.84 indicates a rather expensive valuation of ABL.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ABL is on the same level as its industry peers.
  • ABL's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.10.
Industry RankSector Rank
PE 19.92
Fwd PE 17.84
ABL.DE Price Earnings VS Forward Price EarningsABL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

  • ABL's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Based on the Price/Free Cash Flow ratio, ABL is valued a bit cheaper than the industry average as 67.21% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 24.08
EV/EBITDA 15.92
ABL.DE Per share dataABL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • ABL's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of ABL may justify a higher PE ratio.
PEG (NY)1.73
PEG (5Y)2.79
EPS Next 2Y10.76%
EPS Next 3Y10.34%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. ABL.DE Dividend Analysis

5.1 Amount

  • ABL has a Yearly Dividend Yield of 2.41%.
  • ABL's Dividend Yield is a higher than the industry average which is at 1.14.
  • Compared to an average S&P500 Dividend Yield of 1.89, ABL pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.41%

5.2 History

  • On average, the dividend of ABL grows each year by 10.37%, which is quite nice.
Dividend Growth(5Y)10.37%
Div Incr Years6
Div Non Decr Years6
ABL.DE Yearly Dividends per shareABL.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • 63.09% of the earnings are spent on dividend by ABL. This is not a sustainable payout ratio.
  • ABL's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP63.09%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
ABL.DE Yearly Income VS Free CF VS DividendABL.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
ABL.DE Dividend Payout.ABL.DE Dividend Payout, showing the Payout Ratio.ABL.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ABL.DE Fundamentals: All Metrics, Ratios and Statistics

ABBOTT LABORATORIES

FRA:ABL (3/31/2026, 1:19:48 PM)

89.24

-0.48 (-0.53%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22
Earnings (Next)04-14
Inst Owners81.83%
Inst Owner ChangeN/A
Ins Owners0.47%
Ins Owner ChangeN/A
Market Cap155.07B
Revenue(TTM)44.33B
Net Income(TTM)6.52B
Analysts80
Price Target114.26 (28.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.41%
Yearly Dividend2.06
Dividend Growth(5Y)10.37%
DP63.09%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.9%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.75%
EPS beat(4)1
Avg EPS beat(4)-0.41%
Min EPS beat(4)-1.06%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.09%
EPS beat(12)6
Avg EPS beat(12)0.64%
EPS beat(16)10
Avg EPS beat(16)5.12%
Revenue beat(2)0
Avg Revenue beat(2)-2.58%
Min Revenue beat(2)-3.88%
Max Revenue beat(2)-1.29%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-3.88%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-1.18%
Revenue beat(12)3
Avg Revenue beat(12)-0.45%
Revenue beat(16)7
Avg Revenue beat(16)1.23%
PT rev (1m)0%
PT rev (3m)-8.26%
EPS NQ rev (1m)-0.05%
EPS NQ rev (3m)-4.38%
EPS NY rev (1m)0.03%
EPS NY rev (3m)0.19%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)-2%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-0.91%
Valuation
Industry RankSector Rank
PE 19.92
Fwd PE 17.84
P/S 4.02
P/FCF 24.08
P/OCF 18.62
P/B 3.42
P/tB 7.89
EV/EBITDA 15.92
EPS(TTM)4.48
EY5.02%
EPS(NY)5
Fwd EY5.6%
FCF(TTM)3.71
FCFY4.15%
OCF(TTM)4.79
OCFY5.37%
SpS22.21
BVpS26.12
TBVpS11.31
PEG (NY)1.73
PEG (5Y)2.79
Graham Number51.31
Profitability
Industry RankSector Rank
ROA 7.52%
ROE 12.51%
ROCE 11.9%
ROIC 9.17%
ROICexc 10.51%
ROICexgc 20.3%
OM 18.85%
PM (TTM) 14.72%
GM 56.68%
FCFM 16.68%
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
ROICexc(3y)9.83%
ROICexc(5y)11.21%
ROICexgc(3y)21.64%
ROICexgc(5y)29.96%
ROCE(3y)11.19%
ROCE(5y)12.44%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-6%
ROICexc growth 3Y-8.69%
ROICexc growth 5Y6.09%
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
F-Score6
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.75
Debt/EBITDA 0.86
Cap/Depr 69.67%
Cap/Sales 4.9%
Interest Coverage 15.33
Cash Conversion 83.39%
Profit Quality 113.35%
Current Ratio 1.58
Quick Ratio 1.18
Altman-Z 4.87
F-Score6
WACC10.38%
ROIC/WACC0.88
Cap/Depr(3y)68.72%
Cap/Depr(5y)62.77%
Cap/Sales(3y)5.22%
Cap/Sales(5y)4.82%
Profit Quality(3y)83.05%
Profit Quality(5y)96.8%
High Growth Momentum
Growth
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
EPS Next Y11.53%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
EPS Next 5Y10.38%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
Revenue Next Year6.97%
Revenue Next 2Y7.18%
Revenue Next 3Y7.13%
Revenue Next 5Y7.06%
EBIT growth 1Y18.75%
EBIT growth 3Y-1.48%
EBIT growth 5Y8.93%
EBIT Next Year25.72%
EBIT Next 3Y14.17%
EBIT Next 5Y13.17%
FCF growth 1Y16.44%
FCF growth 3Y-1.78%
FCF growth 5Y5.26%
OCF growth 1Y11.78%
OCF growth 3Y-0.05%
OCF growth 5Y3.9%

ABBOTT LABORATORIES / ABL.DE Fundamental Analysis FAQ

What is the fundamental rating for ABL stock?

ChartMill assigns a fundamental rating of 7 / 10 to ABL.DE.


Can you provide the valuation status for ABBOTT LABORATORIES?

ChartMill assigns a valuation rating of 4 / 10 to ABBOTT LABORATORIES (ABL.DE). This can be considered as Fairly Valued.


What is the profitability of ABL stock?

ABBOTT LABORATORIES (ABL.DE) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for ABL stock?

The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABL.DE) is 19.92 and the Price/Book (PB) ratio is 3.42.


How sustainable is the dividend of ABBOTT LABORATORIES (ABL.DE) stock?

The dividend rating of ABBOTT LABORATORIES (ABL.DE) is 6 / 10 and the dividend payout ratio is 63.09%.